NO2015006I1 - Flutemetamol (18F) - Google Patents

Flutemetamol (18F)

Info

Publication number
NO2015006I1
NO2015006I1 NO2015006C NO2015006C NO2015006I1 NO 2015006 I1 NO2015006 I1 NO 2015006I1 NO 2015006 C NO2015006 C NO 2015006C NO 2015006 C NO2015006 C NO 2015006C NO 2015006 I1 NO2015006 I1 NO 2015006I1
Authority
NO
Norway
Prior art keywords
fluoromethamol
Prior art date
Application number
NO2015006C
Other languages
English (en)
Norwegian (no)
Other versions
NO2015006I2 (ru
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO2015006I2 publication Critical patent/NO2015006I2/no
Publication of NO2015006I1 publication Critical patent/NO2015006I1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO2015006C 2007-08-30 2015-02-18 Flutemetamol (18F) NO2015006I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96890407P 2007-08-30 2007-08-30
PCT/EP2008/061275 WO2009027452A2 (en) 2007-08-30 2008-08-28 Radiopharmaceutical composition

Publications (2)

Publication Number Publication Date
NO2015006I2 NO2015006I2 (ru) 2015-02-18
NO2015006I1 true NO2015006I1 (no) 2015-03-02

Family

ID=40029249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2015006C NO2015006I1 (no) 2007-08-30 2015-02-18 Flutemetamol (18F)

Country Status (21)

Country Link
US (1) US8916131B2 (ru)
EP (1) EP2182988B1 (ru)
JP (1) JP5367708B2 (ru)
KR (1) KR101571572B1 (ru)
CN (1) CN101790387B (ru)
AU (1) AU2008292201B2 (ru)
BR (1) BRPI0815129B8 (ru)
CA (1) CA2694084C (ru)
DK (1) DK2182988T3 (ru)
ES (1) ES2464715T3 (ru)
HK (1) HK1146710A1 (ru)
HU (1) HUS1500007I1 (ru)
IL (1) IL203316A (ru)
MX (1) MX2010002196A (ru)
NO (1) NO2015006I1 (ru)
NZ (1) NZ583616A (ru)
PL (1) PL2182988T3 (ru)
PT (1) PT2182988E (ru)
RU (1) RU2475267C2 (ru)
WO (1) WO2009027452A2 (ru)
ZA (1) ZA201000718B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2509637T3 (pl) 2009-10-08 2016-12-30 Sposób oczyszczania
BR112014024997B1 (pt) 2012-04-10 2021-03-09 Lantheus Medical Imaging, Inc. métodos de síntese radiofarmacêutica
RU2719399C2 (ru) 2014-12-04 2020-04-17 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ удаления ацетальдегида из радиоактивных фармацевтических препаратов
JP6485914B2 (ja) * 2015-10-28 2019-03-20 日本メジフィジックス株式会社 フルテメタモルの製造方法
JP6955347B2 (ja) 2017-02-28 2021-10-27 日本メジフィジックス株式会社 フルテメタモルの製造方法
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
WO2021195414A1 (en) * 2020-03-27 2021-09-30 Jubilant Pharma Holdings Inc. Radiopharmaceutical dispensing system
US11878081B1 (en) 2022-12-23 2024-01-23 Tap Pharmaceuticals Ag Pharmaceutical formulations of tafamidis
US11980685B1 (en) 2022-12-23 2024-05-14 Tap Pharmaceuticals, Ag Liquid pharmaceutical formulations of tafamidis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
GB9919673D0 (en) * 1999-08-20 1999-10-20 Cancer Res Campaign Tech 2-Arlybenzazole compounds
EP2264018B1 (en) * 2000-08-24 2015-02-11 University of Pittsburgh - Of the Commonwealth System of Higher Education Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
EP1474178A1 (en) * 2002-02-13 2004-11-10 Amersham plc Benzothiazole derivatives for in vivo imaging of amyloid plaques
CA2438032C (en) * 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
US20050043523A1 (en) * 2003-08-22 2005-02-24 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
JP2008505115A (ja) * 2004-07-02 2008-02-21 ユニバーシティー オブ ピッツバーグ 抗アミロイド治療の有効性に対する代用マーカーとしてのアミロイドイメージング
BRPI0512932A (pt) * 2004-07-02 2008-04-15 Univ Pittsburgh compostos e métodos de identificação e de diagnóstico de paciente como prodrÈmico para doença associada com a deposição amilóide
CA2617319A1 (en) 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
AU2006320556A1 (en) * 2005-12-01 2007-06-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
US7858803B2 (en) * 2007-04-27 2010-12-28 The General Hospital Corporation Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders

Also Published As

Publication number Publication date
PL2182988T3 (pl) 2015-02-27
DK2182988T3 (da) 2014-05-26
ZA201000718B (en) 2010-10-27
ES2464715T3 (es) 2014-06-03
RU2475267C2 (ru) 2013-02-20
CA2694084C (en) 2015-07-07
NO2015006I2 (ru) 2015-02-18
BRPI0815129B8 (pt) 2021-05-25
NZ583616A (en) 2012-06-29
AU2008292201A1 (en) 2009-03-05
EP2182988B1 (en) 2014-04-16
US20110008254A1 (en) 2011-01-13
HK1146710A1 (en) 2011-07-08
WO2009027452A2 (en) 2009-03-05
US8916131B2 (en) 2014-12-23
WO2009027452A3 (en) 2009-09-03
JP5367708B2 (ja) 2013-12-11
CN101790387B (zh) 2013-03-20
RU2010101935A (ru) 2011-10-10
MX2010002196A (es) 2010-03-18
HUS1500007I1 (hu) 2021-05-07
KR101571572B1 (ko) 2015-11-24
EP2182988A2 (en) 2010-05-12
IL203316A (en) 2015-02-26
BRPI0815129B1 (pt) 2021-01-12
CA2694084A1 (en) 2009-03-05
BRPI0815129A2 (pt) 2015-02-03
AU2008292201B2 (en) 2014-09-04
PT2182988E (pt) 2014-05-16
CN101790387A (zh) 2010-07-28
JP2010536931A (ja) 2010-12-02
KR20100055440A (ko) 2010-05-26

Similar Documents

Publication Publication Date Title
LU92600I2 (fr) Sovaldi (sofosbuvir)
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
DE602008002772D1 (de) Polyvinylpyrrolidonpulverzusammensetzungen
DE112008003636A5 (de) Mehrzuggruppierer
DE502007001207D1 (de) Elektrosaugkopf
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
NO2015006I1 (no) Flutemetamol (18F)
DE602008000923D1 (de) Einzelwaferätzgerät
BRPI0812840A2 (pt) 2-imidazolinas
DE602008000749D1 (de) Buschschneider
AT505058A3 (de) Türschliesssystem
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
DE602008004695D1 (de) Katalysatorträgerwabe
BRPI0812994A2 (pt) Microbiocidas
DE602008001234D1 (de) Bandmaterialzuführvorrichtung
DE602008005950D1 (de) Münzvereinzeler
DE112008001216A5 (de) Magnetronplasmaanlage
DE502008001694D1 (de) Mitfahrhubwagen
DE602008005589D1 (de) Rliganden
DE602008001674D1 (de) Wimpernwickler
DE112008003094A5 (de) Geomatte
DE502008003063D1 (de) Magnetventilinjektor

Legal Events

Date Code Title Description
MK1K Patent expired